All articles by Katrina Megget – Page 2
-
Business
Allergan steps away from generics with sale to Teva
$40.5 billion deal gives Allergan cash to clear debt and fund further acquisitions, and catapults Teva into global pharma top 10
-
Feature
Of mice and men
2009 marked the first year that more genetically modified animals were used in UK scientific procedures than animals deemed 'genetically normal'. Katrina Megget investigates
-
News
Mapping brain networks
Model ring-shaped neuronal networks for unravelling memory, learning and cognition processes
-
Feature
Idle cures
Taking a coffee break could help find cures for cancer or Aids. Katrina Megget looks at the future of research that harnesses the computing power of the World Community Grid
-
Feature
Roadblock on memory lane
The ability to wipe out traumatic memories is just around the corner. Katrina Megget looks into the science of forgetting
-
News
Tripping over red tape
Therapeutic treatments based on street drugs could be creeping closer as a cannabis-based drug hopes for UK approval
- Previous Page
- Page1
- Page2
- Next Page